leisure time -WSS

leisure time

author：comprehensive 2025-09-30 12:08:11 - browse：534

Novo Nordisk headquarters -- health coverage from STAT — Novo Nordisk's headquarters, outside Copenhagen, Denmark. LISELOTTE SABROE/Scanpix/AFP via Getty Images

Novo Nordisk is pausing ads for its obesity drug Wegovy as it struggles to keep up with surging demand, the latest hurdle in its rollout of the weight loss drug.

“To avoid stimulating further demand for this medicine, we’re pausing some key Wegovy promotional efforts,” the Danish drugmaker said in an emailed statement. “We are pausing all local television advertising and postponing planned national television advertising for Wegovy. We are also assessing our promotional efforts to healthcare professionals and adjusting accordingly.” The news was earlier reported by Endpoints.

Wegovy, which contains the active ingredient semaglutide, has become immensely popular for its effectiveness in helping people lose weight and is helping usher in what many see as a sea change in obesity treatment. Its sister drug for diabetes, Ozempic, has also been in demand for a similar effect on weight loss.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

WSS

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Dario to buy mental health app maker Twill in cash and stock deal

Dario to buy mental health app maker Twill in cash and stock deal

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

ER docs worry over extreme heat as a 'mass casualty event'

explore

leisure time

knowledge

Medical leaders decry Supreme Court decision on affirmative action

FDA seeking to stop procedures at two unregulated stem cell clinics

Guidelines to prevent youth baseball injuries need more muscle

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Sports medicine is finally prioritizing gender equality

Dario to buy mental health app maker Twill in cash and stock deal

Sports medicine is finally prioritizing gender equality

More hospitals are billing patients as online messages surge

United colonoscopy coverage change 'may cost lives,' doctors say

More hospitals are billing patients as online messages surge

explore

ER docs worry over extreme heat as a 'mass casualty event'

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

In utero gene editing: an explainer

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

The Harvard botanist who searched for psychedelics in the Amazon

Johnson & Johnson sues to stop Medicare negotiation

knowledge

Wikipedia

leisure time

knowledge